Michael R Ladomery
Overview
Explore the profile of Michael R Ladomery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calin G, Hube F, Ladomery M, Delihas N, Ferracin M, Poliseno L, et al.
Noncoding RNA
. 2024 Dec;
10(6.
PMID: 39728607
The Journal Editorial Board Members would like to congratulate Victor Ambros and Gary Ruvkun, who were jointly awarded the 2024 Nobel Prize in Physiology or Medicine for their groundbreaking discovery...
2.
Hajjawi M, Wang Q, Presneau N, Ladomery M
Br J Biomed Sci
. 2024 Sep;
81:13618.
PMID: 39310853
No abstract available.
3.
Drozdz J, Ladomery M
Br J Biomed Sci
. 2024 Jul;
81:12054.
PMID: 38952614
The peer review process is a fundamental aspect of modern scientific paper publishing, underpinning essential quality control. First conceptualised in the 1700s, it is an iterative process that aims to...
4.
Asurappulige H, Ladomery M, Ruth Morse H
Transl Oncol
. 2024 Jun;
46:102030.
PMID: 38870677
Following infection or exposure to therapeutic agents, an aggressive immune response may result, termed cytokine storm (CS) or cytokine release syndrome. Here the innate immune system becomes uncontrolled, leading to...
5.
Dlamini Z, Ladomery M, Kahraman A
Front Endocrinol (Lausanne)
. 2024 Jun;
15:1422599.
PMID: 38832352
RNA biology has revolutionized cancer understanding and treatment, especially in endocrine-related malignancies. This editorial highlights RNA's crucial role in cancer progression, emphasizing its influence on tumor heterogeneity and behavior. Processes...
6.
Uzor S, Porazinski S, Li L, Clark B, Ajiro M, Iida K, et al.
Sci Rep
. 2021 Apr;
11(1):7963.
PMID: 33846420
Dysregulation of alternative splicing is a feature of cancer, both in aetiology and progression. It occurs because of mutations in splice sites or sites that regulate splicing, or because of...
7.
Bowler E, Ladomery M
Methods Mol Biol
. 2019 Jun;
1990:109-133.
PMID: 31148067
A hypoxic environment can be defined as a region of the body or the whole body that is deprived of oxygen. Hypoxia is a feature of many diseases, such as...
8.
Williams E, Whiteman M, Wood M, Wilson I, Ladomery M, Allainguillaume J, et al.
Methods Mol Biol
. 2019 Jun;
1990:27-42.
PMID: 31148060
The modification of proteins is a key way to alter their activity and function. Often thiols, cysteine residues, on proteins are attractive targets for such modification. Assuming that the thiol...
9.
Jumbe S, Porazinski S, Oltean S, Mansell J, Vahabi B, Wilson I, et al.
Transl Oncol
. 2018 Oct;
12(1):134-142.
PMID: 30296658
The oncogene ERG encodes an ETS family transcription factor and is implicated in blood, vascular, and bone development and in prostate, blood, and bone cancer. The ERG gene is alternatively...
10.
Adamo P, Porazinski S, Rajatileka S, Jumbe S, Hagen R, Cheung M, et al.
Oncol Lett
. 2017 Nov;
14(5):5605-5610.
PMID: 29113189
The oncogene ETS-related gene (ERG) encodes a transcription factor with roles in the regulation of haematopoiesis, angiogenesis, vasculogenesis, inflammation, migration and invasion. The oncogene is activated in >50% of prostate...